Salix Pharmaceuticals Ltd (SLXP.OQ)
SLXP.OQ on NASDAQ Stock Exchange Global Select Market
75.53USD
1 Aug 2013
75.53USD
1 Aug 2013
Price Change (% chg)
$1.63 (+2.21%)
$1.63 (+2.21%)
Prev Close
$73.90
$73.90
Open
$74.64
$74.64
Day's High
$75.84
$75.84
Day's Low
$73.82
$73.82
Volume
359,856
359,856
Avg. Vol
233,071
233,071
52-wk High
$75.84
$75.84
52-wk Low
$37.55
$37.55
About
Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. As of December 31, 2012, the Company’s products included... (more)
Overall
| Beta: | 0.63 |
| Market Cap (Mil.): | $4,530.42 |
| Shares Outstanding (Mil.): | 61.30 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| SLXP.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 60.62 | 37.93 | 37.76 |
| EPS (TTM): | 1.22 | -- | -- |
| ROI: | 4.81 | 19.48 | 18.76 |
| ROE: | 14.45 | 20.17 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Takeda Pharmaceutical Company Limited (4502.T) | ¥4,635 | +55.00 |
| Ranbaxy Laboratories Limited (RANB.NS) | Rs271.90 | +9.55 |
| Nestle SA (NESN.VX) | CHF63.25 | +0.55 |
| Pfizer Inc. (PFE.N) | $29.11 | -0.12 |
| Abbott Laboratories (ABT.N) | $36.84 | +0.21 |
| Bayer AG (BAYGn.DE) | €89.40 | -0.03 |
| Bayer AG (BAYE.F) | -- | -- |
| GlaxoSmithKline plc (GSK.L) | 1,718.00p | +5.50 |
| Medtronic, Inc. (MDT.N) | $55.49 | +0.25 |
| Shire PLC (SHP.L) | 2,443.00p | +3.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$25.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

